S
Suzanne Oparil
Researcher at University of Alabama at Birmingham
Publications - 941
Citations - 122414
Suzanne Oparil is an academic researcher from University of Alabama at Birmingham. The author has contributed to research in topics: Blood pressure & Angiotensin II. The author has an hindex of 106, co-authored 885 publications receiving 113983 citations. Previous affiliations of Suzanne Oparil include Michigan State University & Oregon Health & Science University.
Papers
More filters
Journal ArticleDOI
Dietary salt reduction in hypertension--what is the evidence and why is it still controversial?
TL;DR: Although the evidence available linking sodium intake and blood pressure in the general population is weak, sodium reduction has been shown to be useful in hypertensive patients, particularly salt-sensitive patients.
Journal ArticleDOI
24-Hour Efficacy and Safety of Triple-Combination Therapy With Olmesartan, Amlodipine, and Hydrochlorothiazide: The TRINITY Ambulatory Blood Pressure Substudy
Joseph L. Izzo,Steven G. Chrysant,Dean J. Kereiakes,Thomas Littlejohn,Suzanne Oparil,Michael Melino,James Lee,Victor Fernandez,Reinilde Heyrman +8 more
TL;DR: This poster presents a probabilistic procedure to assess the importance of baseline IgE levels in the decision-making process for ART and its applications in the context of ART-informed medicine.
Journal ArticleDOI
Mortality and Morbidity During and After Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Results by Sex
Suzanne Oparil,Barry R. Davis,William C. Cushman,Charles E. Ford,Curt D. Furberg,Gabriel B. Habib,L. Julian Haywood,Karen L. Margolis,Jeffrey L. Probstfield,Paul K. Whelton,Jackson T. Wright +10 more
TL;DR: In this article, the authors carried out a prespecified subgroup analysis of 15 638 women and 17 719 men in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) to determine whether an angiotensin-converting enzyme inhibitor (lisinopril) or calcium channel blocker (amlodipine) is superior to a diuretic (chlorthalidone) in reducing cardiovascular disease incidence in sex subgroups.
Journal ArticleDOI
2018 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension.
TL;DR: This issue of Blood Pressure proudly presents the 2018 Practice Guidelines for the Management of Arterial Hypertension, a paper developed by the ESH Writing Task Force for the management of Artership, exclusively for Blood Pressure and Journal of Hypertensions, and endorsed byThe ESH.
Journal ArticleDOI
Atrial natriuretic peptide lowers pulmonary arterial pressure in hypoxia-adapted rats.
TL;DR: Data indicate that ANP lowers pulmonary arterial pressure in rats with hypoxia-induced pulmonary hypertension, mainly by a direct vasodilator effect on the pulmonary vasculature.